Budesonide inhalation suspension versus methylprednisolone for treatment of moderate bronchial asthma attacks

Conclusion In patients with recurrent wheezing or bronchial asthma of <5 years, the efficacy of BIS is equivalent or better than mPSL for moderate bronchial asthma attacks, and in contrast to steroid treatment, BIS treatment do not suppress adrenocortical function.
Source: World Allergy Organization Journal - Category: Allergy & Immunology Source Type: research